ACS Clinical Research Program
Response to preoperative endocrine therapy in breast cancer patients can alter surgical and chemotherapy options(Comments Off on Response to preoperative endocrine therapy in breast cancer patients can alter surgical and chemotherapy options)
The uptake of neoadjuvant endocrine therapy in the U.S. has been slow according to the authors of this month’s column, even though this treatment can reduce the extent of breast surgery.
Improving resection rates in borderline resectable pancreatic cancer: Pilot study shows favorable results
The clinical importance of the Alliance A021101 cooperative group study as well as the design of the trial itself are the focus of this month’s column.
This month’s column summarizes the ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) platform and how it facilities definitive studies of adjuvant targeted therapies in biomarker-selected non-small cell lung cancer patients.
The S0820 Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES) study seeks to determine whether two drugs that have shown early promise can significantly lower the risk of secondary colorectal polyp or cancer for these survivors.
This column addresses the efficacy of combining existing approaches with active therapeutic combinations to treat cancers of the stomach and esophagus.
More in this category
- New manual for cancer surgery issued: Operative Standards for Cancer Surgery
- Limited resection as a cure for early lung cancer: Time to challenge the gold standard?
- Progress in the PROSPECT trial: Precision treatment for rectal cancer?
- Colorectal cancer metastatic to the liver: Making the unresectable resectable
- QOL concerns in surgical patients: Assessment and intervention
- Treating metastatic prostate cancer now and in the future
- NCDB and ACS-CRP: Working together to develop risk-stratified strategies for surveillance
- SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy
- Neoadjuvant cancer therapy: Benefitting patients and improving cancer care
- Patient quality of life: Vitally important
- Community-based physicians and hospitals need to participate in clinical trials
- Less invasive option for small hepatocellular carcinoma: Thermal ablation as first-line therapy?
- Patient-centered outcomes research: Is this really something new?
- Does altering diet affect progression of prostate cancer? The MEAL study
- American College of Surgeons Commission on Cancer Rapid Quality Reporting System: From quality measurement to quality improvement